IN VIVO INTERACTION OF PROPYLTHIOURACIL WITH SODIUM IODIDE (Na131I) RADIOPHARMACEUTICAL IN RATS (Rattus norvegicus) by Daruwati, Isti et al.
In Vivo Interaction of Propylthiouracil Wit Sodium Iodide (Na131I) 
Radioprmaceutical in Rats (Rattus norvegicus) 
ISSN 1411 - 3481 
EISSN 2503 - 1287 
(Isti Daruwati) 
 
  
 
85 
IN VIVO INTERACTION OF PROPYLTHIOURACIL WITH SODIUM IODIDE (Na131I) 
RADIOPHARMACEUTICAL IN RATS (Rattus norvegicus) 
  
Isti Daruwati1, Iim Halimah1, Isa Mahendra1, Dwi Deasy F2, A. Hanafiah WS2 
 
1Center for Applied Nuclear Science and Technology, National Nuclear Agency  
Tamansari 71, Bandung 40132 
2Indonesian Higher Scool of Pharmacy, Soekarno Hatta 354, Bandung 
isti@batan.go.id 
 
 Diterima: 03-05-2017 
Diterima dalam bentuk revisi: 30-08-2017 
Disetujui: 19-09-2017 
 
ABSTRACT 
 
IN VIVO INTERACTION OF PROPYLTHIOURACIL WITH SODIUM IODIDE (Na131I) 
RADIOPHARMACEUTICAL IN RATS (Rattus norvegicus). The aim of this research is to 
determine the effect of propylthiouracil (PTU) treatment to pharmacokinetics interaction and 
biodistribution profile of Na131I radiopharmaceuticals. Three groups of animal model were used 
in this experiment, i.e. experimental animals which given PTU for 1 time (onset or A groups), 
PTU for six days (B Groups) and without treatment (control or C Groups). Pharmacokinetics and 
biodistribution test were conducted by giving PTU per oral and after 24 hours, continued by 
giving Na131I solution per oral. In pharmacokinetics test, percentage of injection dose/gram of 
blood (%ID/g) was calculated to determine the absorption, distribution and elimination half time. 
In biodistribution test, percentage of injection dose/gram of organs was calculated to determine 
the accumulation of Na131I in spesific organs. The results showed that the absorption half time 
of A, B and C groups were 3.14 ± 1.42, 2.49 ± 0.49 and 2.52 ± 0.7 hours, respectively. The 
distribution half time of A, B and C groups were 10.58 + 5.85, 12.92 + 3.75 and 11.42 + 3.15 
hours, respectively. The elimination half time of A, B and C groups were 113.03 + 46.03,  
96.57+ 47.76 and 196.71 + 145.21 hours, respectively. Biodistribution test results showed that 
the accumulation of Na131I in thyroid of A, B and C groups were 1.31 + 0.45, 5.03 + 0.55 and 
4.45 + 2.24% respectively. This research was concluded that onset and long term PTU 
administration cannot alter absorption, distribution, and elimination half time Na131I, and 
administration PTU by onset can decrease accumulation of Na131I on thyroid, different with 
administration PTU in long term which can not alter accumulation of Na131I on thyroid. 
 
Keywords: Iodine-131, propylthiouracil, in vivo interaction, pharmacokinetics, biodistribution. 
 
 
ABSTRAK 
 
INTERAKSI IN VIVO PROPILTIOURASIL TERHADAP RADIOFARMAKA SODIUM 
IODIDA (Na131I) PADA TIKUS (Rattus norvegicus). Tujuan penelitian ini untuk menentukan 
efek pemberian Propiltiourasil (PTU) terhdap interaksi farmakokinetik dan profil Na131I. Tiga 
kelompok hewan model digunakan, yaitu hewan coba yang diberi PTU 1 kali (onset atau grup 
A), PTU selama 6 hari (grup B), dan tanpa perlakuan (kontrol atau grup C). Uji farmakokinetik 
dan biodistribusi dilakukan dengan memberikan PTU secara per oral, setelah 24 jam dilanjutkan 
pemberian larutan Na131I secara per oral. Pada uji farmakokinetik, persentase  dosis injeksi per 
gram darah (%ID/g) dihitung untuk menentukan waktu paruh absorpsi, distribusi dan  eliminasi. 
Pada uji biodistribusi, persentase  dosis injeksi per gram organ dihitung untuk menentukan 
akumulasi Na131I pada organ spesifik. Hasil penelitian menunjukkan waktu paruh absorpsi dari 
grup A, B dan C masing-masing 3.14 ± 1.42, 2.49 ± 0.49 dan 2.52 ± 0.7 jam. Waktu paruh 
distribusi dari grup A, B dan C masing-masing 10.58 + 5.85, 12.92 + 3.75 and 11.42 + 3.15 jam. 
Waktu paruh eliminasi dari grup A, B dan C masing-masing 113.03 + 46.03, 96.57+ 47.76 and 
196.71 + 145.21 jam. Hasil uji biodistribusi menunjukkan Na131I di tiroid dari grup A, B dan C 
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masing-masing adalah 1.31 + 0.45, 5.03 + 0.55 and 4.45 + 2.24%. Penelitian ini menyimpulkan 
bawa pemberian PTU secara onset dan jangka panjang tidak mengubah absorpsi, distribusi, 
dan eliminasi dari Na131I, namun terjadi penurunan akumulasi Na131I di tiroid pada pada 
pemberian PTU secara onset, berbeda dengan pemberian PTU jangka panjang yang tidak 
merubah akumulasi Na131I di tiroid. 
 
Kata kunci: Iodine-131, propiltiourasil, interaksi in vivo, farmakokinetik, biodistribusi. 
 
 
 
1. INTRODUCTION 
Hyperthyroidism is a pathological 
disorder in which excess thyroid hormone is 
synthesized and secreted by the thyroid 
gland beyond the normal content range. 
Hyperthyroidism can be overt or subclinical. 
Over hyperthyroidism is characterized by 
low serum thyroid stimulating hormone 
(TSH) concentrations and raised serum 
concentrations of thyroid hormones: 
thyroxine (T4), tri-iodothyronine (T3), or both. 
Subclinical hyperthyroidism is characterized 
by low serum TSH, but normal serum T4 
and T3 concentrations. The three options for 
treating patients with hyperthyroidism are 
antithyroid drugs (ATDs), radioactive iodine 
ablation, and surgery (1,2). 
Sodium iodide (Na131I) 
radiopharmaceuticals usually used to 
therapy of hyperthyroidism in nuclear 
medicine. Radioiodine therapy is considered 
definitive therapies surgery, since the 
primary goal of this approach to treatment is 
to destroy hyperfunctioning thyroid tissue by 
its beta emission. Beta emission is well-
known for causing death of cells because it 
can penetrate other cells up to several 
millimeters away. I-131 effectively ablating 
functional thyroid tissue over the course of 6 
to 18 weeks or more. It is administered orally 
with activities of 1-5 mCi or less. Radioiodine 
(I-131) use has advantages of low cost and 
a long half-life until 8.2 days. (3-6). 
Thionamides, a class of anti thyroid 
drugs (ATDs), are compounds that are 
known to inhibit thyroid hormone synthesis 
via the inhibition of organification of iodine to 
tyrosine residues in thyroglobulin and the 
coupling of iodotyrosines. The commonly 
available thionamides are Propylthiouracil 
(PTU). PTU is generally used to restore 
euthyroidism before definitive treatment with 
radioactive iodine and usually before 
surgery (1,3,6). 
PTU can be used in combination with 
radioactive iodium to accelerate clinical 
improvement while waiting for the 
therapeutic effect of radioactive iodium (7). 
There is known considerable evidence that 
radiopharmaceutical biodistribution or 
pharmacokinetics may become altered by a 
variety of drugs. Remaining ignorant of such 
factors (interactions-drug interactions) can 
lead to a state of total disorder(8,9).  
The aim of this research was to 
determine the effect of PTU treatment to 
pharmacokinetics interaction and 
biodistribution profile of Na131I 
radiopharmaceuticals on rats (Rattus 
norvegicus) Sprague dawley stock and 
interpretate drug-radiopharmaceutical 
interaction to pharmacokinetics and 
biodistribution profile of Na131I. The results 
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are expected could be used by the doctor in 
nuclear medicine to interpretate imaging 
result which is intervened by drug interaction.  
 
2. METHODS 
2.1. Materials and Instruments 
The materials are Na131I solution 
(BATAN), 100 mg propyltiourachyl tablet 
(Dexa Medica, Corp) suspended with 1% 
CMC, methanol (Merck), isoflurane, 
aquabidest (IPHA), Whatman no 1 paper 
and universal pH paper.  
The instruments are single channel 
analyzer (Ortec), dose calibrator (Victoreen), 
oven (Memmert), Nuova stirring hot plate 
(Barnstead Thermolyne), analytical balance 
(Mettler Toledo), paper chromatography 
apparatus, vortex (Barnstead Thermolyne), 
rat restrainer, stomach tube for rats, micro-
pippete (Eppendorf) and anaesthesia 
chamber.  
 
2.2. Animals 
Eighteen male rats (Rattus 
norvegicus) Sprague dawley stock, with 5 
weeks age and 200-300 grams of 
bodyweight. These tests used three groups 
of animal model, i.e. experimental animals 
which given PTU with dose 4.2mg/kg 
BW/day for 1 time (onset or A groups), 
animals which given PTU with dose 
4.2mg/kg BW/day for six days (B Groups), 
and animals without treatment (control or C 
Groups). Animals used in the experiments 
received care in compliance with the 
“Principles of Laboratory Animal Care” and 
“Guide for the care and use of Laboratory 
Animals”. 
 
2.3. Radiochemical Purity of Iodine-131 
Radiochemical purity of Iodine-131 
was determined by ascending paper 
chromatography method. Chromatography 
system using Whatmann 1 paper as 
stationery phase and methanol-water  
(80:20) as mobile phase to separate 
impurities(10,11). Paper chromatogram was 
dried in oven at 80OC for 5 minutes and 
every 1 cm piece of paper is measured by 
SCA. Retention factor (Rf) of Iodine-131= 
0.8 and impurities at Rf=0.0 (12).  
 
2.4. Pharmacokinetics Test 
Experimental animals were prepared 
in three groups which consists of 3 rats each 
group. Iodine-131 solution with dose 100 
µCi/100 µL was given per oral to each 
animal model. At specific time intervals post 
giving Iodine-131 solution, blood sampling 
from tail was performed and weighed, then 
counted using Single Channel Analyzer. 
Measurement results were expressed as a 
percentage of Injection Dose per gram of 
blood (%ID/g)(13). Calculating of %ID/g 
using formula (1): 
 
%ID/g = …… (1) 
 
The absorbtion, distribution, and 
elimination half time of Na131I was 
determined from percentage of Injection 
Dose per gram of blood, then described in 
graphic form to obtain the compartment 
equations. Statistical test using ANOVA 
(14,15). 
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2.5. Biodistribution Test 
Biodistribution test was adopted and 
modified by Ocakoglu et al method. 
Experimental animals were prepared in 
three groups which consists of 3 rats each 
group, then Iodine-131solution with dose 
100 µCi/100 µL was given by per oral after 1 
hour (A groups), and 24 hours (B groups) 
post giving PTU. Experimental animals were 
euthanized at 90 minutes post giving Iodine-
131 solution with inhalated anaesthetics 
overdose (isoflurane) then necropted. 
Specific organs i.e. thyroid gland, muscle, 
bone, blood, intestine, gastric, liver, spleen, 
kidney, heart, and lung were collected. 
Every organs were weighed, then counted 
using Single Channel Analyzer. 
Measurement results were expressed as a 
percentage of Injection Dose per gram of 
organs (%ID/g) (13). Calculating of %ID/g 
using formula (2): 
 
%ID/g = …. (2) 
 
Percentage of radioactivity in the 
organ samples was described in the graph 
and statistical test using ANOVA(15,16). 
 
3. RESULT AND BRIEF DISCUSSION 
Radiochemical purity of Na131Isolution 
was obtained 98.42% ± 0.003 (n=3) with pH 
between 8-11 (base solution in NaOH). 
Based on the results of radiochemical purity 
(more than 95%), Na131I solution was fulfilled 
the requirement of Indonesian 
Pharmacopoeia and continued to 
pharmacokinetics and biodistribution test 
(11). As shown on Figure 1, the peak of 
iodine-131 at 0.8 retention factor separated 
from impurities at 0.0 retention factor. 
The pharmacokinetic profiles of Na131I 
radiopharmaceutical shown in Figure 2. 
Peak of radioactivity on the blood of A, B, 
and C groups were 0.26, 0.24 and 0.34%. 
This shows that the pattern of giving iodine-
131 per oral has absorption, distribution and 
elimination pattern, which follows three 
compartments model. The Peak of A and B 
groups occur at 3 hours after giving Na131I 
solution, but on C groups (control) occur at  
1 hour post giving Na131I solution.  It could 
be caused PTU delay the absorption of 
iodine-131 to targeted organ although on 
statistic comparison there was no significant 
difference in all groups. The percentage of 
radioactivity on the blood of A, B, and C 
groups decreased at 72 hours after giving 
Na131I solution, 0.070, 0.006 and 0.032% 
respectively. 
From the calculation of radioactivity 
per gram of blood, acquired biological half-
life data which is divided into absorption, 
distribution and elimination half-life. As 
shown on Table 1, the results of this 
research showed that the absorption half 
time of A, B and C groups were 3.14 ± 1.42, 
2.49 ± 0.49 and 2.52 ± 0.7 hours 
respectively. The distribution half time of A, 
B and C groups were10.58 + 5.85,  
12.92 + 3.75 and 11.42 + 3.15 hours 
respectively.
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Figure 1. Chromatogram of Iodine-131 using whatman No. 1 paper as stationary phase and methanol-
water (80:20) as mobile phase. 
 
 
 
Figure 2. Pharmacokinetics profile of Na131I, Experimental animal which giving PTU for 1 time (A Group); 
Experimental animal which giving PTU for 6 days (B Group) and Control Animal (C Group). 
 
 
The elimination half time of A, B and C 
groups were 113.03 + 46.03, 96.57+ 47.76 
and 196.71 + 145.21 hours respectively. 
Anova test showed that there were no 
significant different between A, B and C 
groups. Although result of anova test show 
that no signifficant different between all 
groups, can be seen on all groups has wide 
standard deviation. It can be caused by 
limitation number of the animals that has 
different physiology system each other.   
The biodistribution test showed that the 
biggest accumulation of Na131I was on 
stomach and thyroid (Table 2). Iodine is a 
substrate for thyroid hormone synthesis and 
is actively transported into the thyroid 
follicular cells by an iodine symporter. It is 
oxidized and covalently bound to the tyrosyl 
residues of thyroglobulin (3). Coupling of 
iodinated tyrosyl residues results in the 
formation of T4 and T3, which are stored 
within the colloid space. Radioiodine (131I) is 
similarly processed. In normal thyroid tissue, 
thyrotropin is required to stimulate iodine 
uptake into follicular cells. 
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Table 1. Biological half time of Na131I with PTU treatment 
Condition  t ½ absorption (hours) t ½ distribution 
(hours) 
t ½ elimination 
(hours) 
Onset (A) 3.14 ± 1.42 10.58 ± 5.85 113.03 ± 46.03 
Long term (B) 2.49 ± 0.49 12.92 + 3.75 96.57+ 47.76 
Control (C) 2.52 ± 0.10 11.42 ±4.45 196.71 + 145.21 
 
Table 2. Biodistribution of Na131I  
Organ Samples A group (%) B group (%) C group (%) 
Muscle 0.065 0.050 0.043 
Thyroid 1.315 4.206 4.454 
Blood 0.498 0.344 0.231 
Intestine 1.557 0.514 0.333 
Liver 0.280 0.151 0.270 
Spleen 0.268 0.188 0.139 
Kidney 0.643 0.231 0.152 
Heart 0.205 0.107 0.124 
Lung 0.441 0.263 0.293 
Stomach 7.929 3.064 4.484 
Bone 0.177 0.136 0.101 
 
 
Radioiodine is processed in a thyroid follicle 
(3). The thyrotropin receptor and the 
sodium–iodine symporter (NIS) are located 
on the basolateral membrane. Iodine is 
actively transported across the apical 
membrane in a pendrin-dependent process. 
In the presence of hydrogen peroxide, 
thyroid peroxidase facilitates the iodination 
of the tyrosyl residues of thyroxin. The 
resulting compound is subsequently coupled 
to form free thyroxine (T4) and 
triiodothyronine (T3) (3). NIS is expressed in 
the thyroid, salivary glands, gastric mucosa, 
and lactating mammary glands. It is also 
detected in the lacrimal glands, choroid 
plexus, ciliary bodies (located in the eyes), 
skin, placenta, and thymus.  
Lower levels of NIS expression are 
seen in the prostate, ovaries, adrenal glands, 
lungs, and heart. In the stomach, NIS may 
be expressed in parietal cells or mucus cells 
of the gastric mucosa. NIS expression has 
been explored as a possible means for 
providing targeted radionuclide therapy(17). 
Biodistribution of Na131I on thyroid 
organs is showed by Figure 3. Results of 
Anova test on thyroid organs showed there 
were significant different between A groups 
(PTU onset) to C groups (Control) and no 
significant between B groups to C groups. It 
could be caused on A groups, Iodide uptake 
by thyroid is inhibited 2-3 hours by PTU and 
on B groups PTU had been excreted.  
Benker et al  explained that antithyroid 
drugs like PTU has striking discrepancy 
between short plasma half time and long 
duration of action of PTU. PTU half time in 
plasma is 1 hour and undetectable after 7-8 
hours. (18).  
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Figure 3. Biodistribution of Na131I on thyroid gland (A: Experimental animal which giving PTU for 1 time 
(Onset); B: Experimental animal which giving PTU for 6 days; C: Control Animal) 
 
PTU has spesific effect to NIS. 
Montoya et al has been explained that PTU 
inhibit the enzyme thyroperoxidase which 
normally acts in thyroid hormone synthesis 
facilitating the addition of iodine to tyrosine 
residues on the hormone precursor 
thyroglobulin. This is one of the essential 
steps in the formation of thyroxine (T4). 
Significant increase of thyroid-free tyrosine 
in animals treated with PTU has been due to 
the decrease of endogenous T4 production 
and subsequent stimulation of endogenous 
TSH release. Sue et al also reported that 
PTU coordinately increased NIS promoter 
activity NIS protein levels. Although NIS 
protein levels were similarly induced by PTU 
and TSH. The size of the resulting proteins 
and their subcellular distribution patterns 
were different. The fully glycosylated NIS 
protein migrates with a molecular weight of 
87–110 kDa. As such. the observed 
differences in molecular weight between 
PTU- and TSH-induced NIS proteins may 
reflect post-translational modifications such 
as glycosylation and phosphorylation so 
PTU-induced NIS protein was relatively 
immature compared to TSH-induced NIS 
protein which could also be consistent with 
the lower Iodide accumulation of the PTU- 
induced NIS protein.   (19,20). 
  
4. CONCLUSION 
This research was concluded that 
PTU for onset or long term treatment cannot 
alter absorption, distribution and elimination 
half time (pharmacokinetics profile) of 
sodium iodide (Na131I) radiopharmaceutical 
and administration PTU in onset for 
pretreatment can decrease accumulation of 
Na131I on thyroid, different with 
administration PTU in long term which can 
not alter accumulation of Na131I on thyroid. 
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